AbbVie and Genentech Join TrumpRx: A Closer Look at the Impact
Abbvie and Genentech are set to launch their medications on the TrumpRx platform, promising significant discounts. But who exactly stands to benefit from these prices? Let's delve into the implications for pharmaceutical accessibility and the broader healthcare landscape.
Read full article




























